[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK1206436T3 - Retinoider til behandling af emfysem - Google Patents

Retinoider til behandling af emfysem

Info

Publication number
DK1206436T3
DK1206436T3 DK00951439T DK00951439T DK1206436T3 DK 1206436 T3 DK1206436 T3 DK 1206436T3 DK 00951439 T DK00951439 T DK 00951439T DK 00951439 T DK00951439 T DK 00951439T DK 1206436 T3 DK1206436 T3 DK 1206436T3
Authority
DK
Denmark
Prior art keywords
retinoids
emphysema
treatment
Prior art date
Application number
DK00951439T
Other languages
English (en)
Inventor
Paula Nanette Belloni
Jean-Marc Lapierre
Michael Klaus
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK1206436T3 publication Critical patent/DK1206436T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07Retinol compounds, e.g. vitamin A
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/57Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/63Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C61/00Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C61/16Unsaturated compounds
    • C07C61/28Unsaturated compounds polycyclic
    • C07C61/29Unsaturated compounds polycyclic having a carboxyl group bound to a condensed ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C63/00Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
    • C07C63/66Polycyclic acids with unsaturation outside the aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C69/753Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring of polycyclic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK00951439T 1999-08-02 2000-07-25 Retinoider til behandling af emfysem DK1206436T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99115223 1999-08-02
EP00951439A EP1206436B1 (en) 1999-08-02 2000-07-25 Retinoids for the treatment of emphysema
PCT/EP2000/007091 WO2001009076A2 (en) 1999-08-02 2000-07-25 Retinoids for the treatment of emphysema

Publications (1)

Publication Number Publication Date
DK1206436T3 true DK1206436T3 (da) 2005-02-14

Family

ID=8238709

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00951439T DK1206436T3 (da) 1999-08-02 2000-07-25 Retinoider til behandling af emfysem

Country Status (18)

Country Link
US (3) US6528677B1 (da)
EP (1) EP1206436B1 (da)
JP (1) JP3961827B2 (da)
KR (1) KR100466730B1 (da)
CN (1) CN1166618C (da)
AR (1) AR024998A1 (da)
AT (1) ATE279386T1 (da)
AU (1) AU772551B2 (da)
BR (1) BR0012951A (da)
CA (1) CA2386793C (da)
DE (1) DE60014928T2 (da)
DK (1) DK1206436T3 (da)
ES (1) ES2228587T3 (da)
MX (1) MXPA02000828A (da)
PT (1) PT1206436E (da)
TR (1) TR200200263T2 (da)
WO (1) WO2001009076A2 (da)
ZA (1) ZA200200516B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2178B1 (en) * 1999-10-19 2003-04-23 اف . هوفمان لاروش ايه جي Treatment of invasive diseases, using selected anti-PAR materials
US20060161076A1 (en) * 2005-01-06 2006-07-20 Diamics, Inc. Systems and methods for collection of cell clusters
US20060189893A1 (en) * 2005-01-06 2006-08-24 Diamics, Inc. Systems and methods for detecting abnormal cells
US7914437B2 (en) * 2005-02-04 2011-03-29 Ams Research Corporation Transobturator methods for installing sling to treat incontinence, and related devices
US9119777B2 (en) 2008-05-30 2015-09-01 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
US8415390B2 (en) 2008-05-30 2013-04-09 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
PL3067054T3 (pl) 2007-09-10 2021-10-04 Boston Biomedical, Inc. Nowe kompozycje i sposoby leczenia nowotworów
BR112012023660B8 (pt) 2010-03-19 2021-05-25 Boston Biomedical Inc usos de uma quantidade terapeuticamente eficaz de um composto, ou de um sal, solvato, hidrato ou pró-fármaco farmaceuticamente aceitável do mesmo para o tratamento de câncer
US8772273B2 (en) 2011-10-04 2014-07-08 Quretino Therapeutics, Inc. Formulations and uses of retinoic acid receptor selective agonists
WO2013058809A1 (en) * 2011-10-19 2013-04-25 Bikam Pharmaceuticals, Inc. Opsin-binding ligands, compositions and methods of use
JP6433085B2 (ja) 2013-04-09 2018-12-05 ボストン バイオメディカル, インコーポレイテッド がんの処置に使用するための2−アセチルナフト[2,3−b]フラン−4,9−ジオン
KR102408261B1 (ko) * 2014-02-03 2022-06-10 비타이 파마슈티컬즈, 엘엘씨 Ror-감마의 디하이드로피롤로피리딘 저해제
PL3207043T6 (pl) 2014-10-14 2020-11-02 Vitae Pharmaceuticals, Llc Inhibitory dihydropirolopirydynowe ror-gamma
US9663515B2 (en) 2014-11-05 2017-05-30 Vitae Pharmaceuticals, Inc. Dihydropyrrolopyridine inhibitors of ROR-gamma
DK3331876T3 (da) 2015-08-05 2021-01-11 Vitae Pharmaceuticals Llc Modulators of ror-gamma
KR20180086221A (ko) 2015-11-20 2018-07-30 비타이 파마슈티컬즈, 인코포레이티드 Ror-감마의 조절물질
TWI757266B (zh) 2016-01-29 2022-03-11 美商維它藥物有限責任公司 ROR-γ調節劑
JP7106563B2 (ja) 2016-11-29 2022-07-26 スミトモ ファーマ オンコロジー, インコーポレイテッド ナフトフラン誘導体、その調製、および使用方法
WO2018213424A1 (en) 2017-05-17 2018-11-22 Boston Biomedical, Inc. Methods for treating cancer
WO2019018975A1 (en) 2017-07-24 2019-01-31 Vitae Pharmaceuticals, Inc. INHIBITORS OF ROR GAMMA
CN111225914B (zh) 2017-07-24 2022-10-11 生命医药有限责任公司 RORγ的抑制剂

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU87821A1 (fr) * 1990-10-12 1992-05-25 Cird Galderma Composes bi-aromatiques,et leur utilisation en medecine humaine et veterinaire et en cosmetique
US5958954A (en) * 1995-09-01 1999-09-28 Allergan Sales, Inc. Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities

Also Published As

Publication number Publication date
AU6437300A (en) 2001-02-19
KR20020030089A (ko) 2002-04-22
MXPA02000828A (es) 2002-07-30
BR0012951A (pt) 2002-04-30
US20050113447A1 (en) 2005-05-26
US6528677B1 (en) 2003-03-04
EP1206436B1 (en) 2004-10-13
EP1206436A2 (en) 2002-05-22
CA2386793A1 (en) 2001-02-08
CN1166618C (zh) 2004-09-15
PT1206436E (pt) 2004-12-31
WO2001009076A2 (en) 2001-02-08
AR024998A1 (es) 2002-11-06
DE60014928T2 (de) 2006-03-09
US6828337B2 (en) 2004-12-07
AU772551B2 (en) 2004-04-29
US20030176726A1 (en) 2003-09-18
ES2228587T3 (es) 2005-04-16
WO2001009076A3 (en) 2001-07-19
CN1368946A (zh) 2002-09-11
ATE279386T1 (de) 2004-10-15
DE60014928D1 (de) 2004-11-18
CA2386793C (en) 2006-03-28
ZA200200516B (en) 2003-06-25
JP2003526626A (ja) 2003-09-09
JP3961827B2 (ja) 2007-08-22
KR100466730B1 (ko) 2005-01-24
TR200200263T2 (tr) 2004-12-21

Similar Documents

Publication Publication Date Title
DK1206436T3 (da) Retinoider til behandling af emfysem
DK1147083T3 (da) Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
DK1259512T3 (da) Pteridinforbindelser til behandling af psoreasis
DK1324970T3 (da) Retinoider til behandling af emfysem
DK1144395T3 (da) 2-amino-benzoxazinon-derivater til behandling af fedme
DK1077940T3 (da) 4-Phenylpiperidiner til behandling af pruritiske dermatoser
DK2412368T3 (da) Sammensætning til behandling af ar
DE60229591D1 (de) Trägerplattenvorrichtung
ATE384903T1 (de) Gewindeverbindung
DK1562932T3 (da) 4 tetrazolyl-4-phenylpiperidinderivater til behandling af smerter
DK1143977T3 (da) 2-oxy-benzoxazinonderivater til behandling af obesitas
ATA206799A (de) Leuchtdioden-signalgeberoptik
DK1392318T3 (da) 15-keto-prostaglandiner til behandling af lægemiddelinduceret forstoppelse
DE60204155D1 (de) Filmmaterial
DK1225878T3 (da) RAR-gamma-selektive retinoidagonister til behandling af emfysem
DK199800837A (da) Anlæg til behandling af emner
DE60234984D1 (de) Trid gegenstand
DE60203401D1 (de) Filmmaterial
DE60214042D1 (de) Nass-trocken-reinigungssystem
DK1200447T3 (da) Oxazinocarbazoler til behandling af CNS-sygdomme
DK1177164T3 (da) Fremgangsmåde til oprensning af diacerein
DK1224181T3 (da) Substituerede pyrroler som antiproliferative midler til behandling af cancer
FI20012516A (fi) Päänviennin menetelmä
DK1451177T3 (da) Substituerede 2-pyrrolidin-2-yl-1H-indol-derivater til behandling af migræne
DE60201909D1 (de) Zoom-verfahren